Mikko Arola
- Epidemiology top 10%
- Pediatrics, Perinatology and Child Health top 2%
- Pulmonary and Respiratory Medicine top 10%
- Otorhinolaryngology top 1%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Olli RuuskanenThedi ZieglerPäivi M. LähteenmäkiLiisa JärveläJussi MertsolaAnne Putto‐LaurilaMatti K. ViljanenOlli J. Heinonen
- Topics
- Childhood Cancer Survivors' Quality of Life (16 papers)Acute Lymphoblastic Leukemia research (8 papers)Respiratory viral infections research (7 papers)
In The Last Decade
Mikko Arola
44 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Epidemiology 468
- Pediatrics, Perinatology and Child Health 422
- Pulmonary and Respiratory Medicine 287
- Otorhinolaryngology 263
- Public Health, Environmental and Occupational Health 252
Countries citing papers authored by Mikko Arola
This map shows the geographic impact of Mikko Arola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Arola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Arola more than expected).
Fields of papers citing papers by Mikko Arola
This network shows the impact of papers produced by Mikko Arola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Arola. The network helps show where Mikko Arola may publish in the future.
Co-authorship network of co-authors of Mikko Arola
This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Arola. A scholar is included among the top collaborators of Mikko Arola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Arola. Mikko Arola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 13 | |
| 3 | 11 | |
| 4 | 3 | |
| 5 | 19 | |
| 6 | 20 | |
| 7 | 32 | |
| 8 | 33 | |
| 9 | [Outcome of childhood cancer in Tampere, Finland]. | 1 |
| 10 | 3 | |
| 11 | 68 | |
| 12 | 6 | |
| 13 | 27 | |
| 14 | 11 | |
| 15 | 13 | |
| 16 | 22 | |
| 17 | 50 | |
| 18 | 70 | |
| 19 | 30 | |
| 20 | 60 |
About Mikko Arola
Mikko Arola is a scholar working on Pediatrics, Perinatology and Child Health, Genetics and Otorhinolaryngology, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (16 papers), Acute Lymphoblastic Leukemia research (8 papers) and Respiratory viral infections research (7 papers). The work is most often cited by research in Otorhinolaryngology (263 citations), Pediatrics, Perinatology and Child Health (422 citations) and Microbiology (85 citations). Mikko Arola has collaborated with scholars based in Finland, Sweden and Denmark. Frequent co-authors include Olli Ruuskanen, Thedi Ziegler, Päivi M. Lähteenmäki, Liisa Järvelä, Jussi Mertsola, Anne Putto‐Laurila, Matti K. Viljanen, Olli J. Heinonen, Jukka Kemppainen and Harri Niinikoski. Their work appears in journals such as PLoS ONE, PEDIATRICS and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.